RenewalBio aims to address the critical shortage of transplantable cells and organs by harnessing advanced stem cell technologies to generate authentic, transplant-ready human cells and tissues. The company’s vision is to unlock the full potential of regenerative medicine, offering new solutions for organ failure, infertility, and age-related diseases. RenewalBio leverages developmental models, coined as Stembroids, that mimic, to some extent, natural embryonic development to produce authentic human cells, bypassing reliance on donor tissues or adult stem cells. Stembroid technology harnesses the incredible potential of induced Pluripotent Stem Cells (iPSCs) as the foundation to generate uniquely tailored transplantable cells for each patient, skillfully emulating natural development through cutting-edge 3D organoid models.